Federated Hermes’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402M Buy
5,133,708
+2,486,265
+94% +$201M 0.58% 40
2026
Q1
$229M Buy
2,647,443
+2,382,582
+900% +$228M 0.37% 58
2025
Q4
$25.4M Sell
264,861
-12,533
-5% -$1.22M 0.04% 400
2025
Q3
$26.4M Sell
277,394
-84,538
-23% -$7.77M 0.05% 377
2025
Q2
$31.5M Sell
361,932
-515
-0.1% -$43.7K 0.06% 343
2025
Q1
$32.6M Buy
362,447
+76,776
+27% +$6.87M 0.07% 312
2024
Q4
$22.8M Sell
285,671
-6,534
-2% -$566K 0.05% 386
2024
Q3
$26.3M Buy
292,205
+96,881
+50% +$8.15M 0.06% 364
2024
Q2
$15.4M Buy
195,324
+10,586
+6% +$868K 0.04% 456
2024
Q1
$16.1M Sell
184,738
-2,218,996
-92% -$189M 0.04% 460
2023
Q4
$198M Sell
2,403,734
-342,712
-12% -$26.1M 0.49% 42
2023
Q3
$215M Sell
2,746,446
-17,715
-0.6% -$1.48M 0.57% 33
2023
Q2
$244M Buy
2,764,161
+29,089
+1% +$2.5M 0.6% 32
2023
Q1
$221M Buy
2,735,072
+120,671
+5% +$9.84M 0.55% 36
2022
Q4
$203M Buy
2,614,401
+1,488,180
+132% +$121M 0.56% 34
2022
Q3
$90.9M Buy
1,126,221
+1,068,661
+1,857% +$96M 0.27% 85
2022
Q2
$5.17M Sell
57,560
-1,966
-3% -$199K 0.01% 677
2022
Q1
$6.61M Sell
59,526
-190,585
-76% -$20.1M 0.01% 714
2021
Q4
$25.9M Sell
250,111
-48,399
-16% -$5.6M 0.05% 435
2021
Q3
$37.4M Sell
298,510
-287
-0.1% -$37.1K 0.07% 339
2021
Q2
$37.1M Sell
298,797
-178,781
-37% -$22.4M 0.07% 344
2021
Q1
$56.4M Sell
477,578
-883
-0.2% -$103K 0.11% 244
2020
Q4
$56M Sell
478,461
-70,764
-13% -$7.79M 0.11% 229
2020
Q3
$57.1M Sell
549,225
-22,110
-4% -$2.22M 0.13% 179
2020
Q2
$52.4M Sell
571,335
-66,171
-10% -$6.35M 0.13% 180
2020
Q1
$57.5M Sell
637,506
-139,763
-18% -$14.9M 0.17% 141
2019
Q4
$88.2M Buy
777,269
+465,037
+149% +$51M 0.2% 117
2019
Q3
$33.9M Buy
312,232
+66,963
+27% +$6.99M 0.08% 249
2019
Q2
$23.9M Sell
245,269
-60,142
-20% -$5.49M 0.06% 311
2019
Q1
$27.8M Sell
305,411
-755
-0.2% -$67.6K 0.07% 275
2018
Q4
$27.8M Buy
306,166
+65,891
+27% +$6.16M 0.08% 267
2018
Q3
$23.6M Sell
240,275
-162,386
-40% -$15M 0.06% 312
2018
Q2
$34.5M Buy
402,661
+149,445
+59% +$12.5M 0.1% 172
2018
Q1
$20.3M Sell
253,216
-19,979
-7% -$1.65M 0.06% 246
2017
Q4
$22.1M Buy
273,195
+106,752
+64% +$8.55M 0.06% 235
2017
Q3
$12.9M Sell
166,443
-173,989
-51% -$14.4M 0.04% 352
2017
Q2
$30.2M Buy
340,432
+159,204
+88% +$13.4M 0.09% 204
2017
Q1
$14.6M Buy
181,228
+26,834
+17% +$2.1M 0.04% 351
2016
Q4
$11M Sell
154,394
-1,240,110
-89% -$97.4M 0.03% 391
2016
Q3
$120M Buy
1,394,504
+2,675
+0.2% +$233K 0.35% 50
2016
Q2
$121M Sell
1,391,829
-25
-0% -$2.02K 0.35% 53
2016
Q1
$104M Buy
1,391,854
+3,348
+0.2% +$252K 0.32% 62
2015
Q4
$107M Sell
1,388,506
-4,327
-0.3% -$326K 0.34% 59
2015
Q3
$93.2M Buy
1,392,833
+73,548
+6% +$5.42M 0.3% 64
2015
Q2
$97.8M Buy
1,319,285
+183,301
+16% +$14M 0.29% 63
2015
Q1
$88.6M Sell
1,135,984
-190,989
-14% -$14.5M 0.27% 72
2014
Q4
$95.8M Sell
1,326,973
-22,920
-2% -$1.59M 0.3% 71
2014
Q3
$83.6M Buy
1,349,893
+44,450
+3% +$2.83M 0.27% 77
2014
Q2
$83.2M Buy
1,305,443
+701,326
+116% +$42.6M 0.26% 74
2014
Q1
$37.2M Buy
604,117
+165,560
+38% +$9.64M 0.12% 170
2013
Q4
$25.2M Buy
438,557
+817
+0.2% +$46.3K 0.09% 214
2013
Q3
$23.3M Sell
437,740
-41,962
-9% -$2.26M 0.09% 184
2013
Q2
$24.7M Buy
+479,702
New +$23.7M 0.1% 178

Other funds holding MDT

Federated Hermes's MDT Position: Q2 2026 in Review

Federated Hermes increased its Medtronic (MDT) stake by 94% in Q2 2026, buying an estimated $201M and bringing the position to 5,133,708 shares worth $402M. The position accounts for 0.58% of the portfolio, ranked #40.

Federated Hermes first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Federated Hermes held 5,133,708 shares of Medtronic worth $402M as of Q2 2026.
  • Federated Hermes bought 2,486,265 Medtronic shares in Q2 2026, an estimated $201M.
  • Medtronic made up 0.58% of Federated Hermes's portfolio in Q2 2026, its #40 holding.
  • Federated Hermes first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.